UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of Encequidar, First-in-Class Intestine Specific P‑glycoprotein Inhibitor

Journal of medicinal chemistry, 2021-04, Vol.64 (7), p.3677-3693

2021

Volltextzugriff (PDF)

Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361)

Journal of medicinal chemistry, 2018-06, Vol.61 (11), p.4704-4719

2018

Volltextzugriff (PDF)

Discovery and Characterization of Potent Dual P‑Glycoprotein and CYP3A4 Inhibitors: Design, Synthesis, Cryo-EM Analysis, and Biological Evaluations

Journal of medicinal chemistry, 2022-01, Vol.65 (1), p.191-216

2022

Volltextzugriff (PDF)

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

Hepatology (Baltimore, Md.), 2002-05, Vol.35 (5), p.1002-1009

2002

Volltextzugriff (PDF)

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

Nature medicine, 2000-12, Vol.6 (12), p.1375-1379

2000

Volltextzugriff (PDF)

Discovery of 4‑Aryl‑N‑arylcarbonyl-2-aminothiazoles as Hec1/Nek2 Inhibitors. Part I: Optimization of in Vitro Potencies and Pharmacokinetic Properties

Journal of medicinal chemistry, 2014-05, Vol.57 (10), p.4098-4110

2014

Volltextzugriff (PDF)

Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1

Journal of experimental & clinical cancer research, 2014-01, Vol.33 (1), p.6-6, Article 6

2014

Volltextzugriff (PDF)

RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg

Science translational medicine, 2017-09, Vol.9 (409)

2017

Volltextzugriff (PDF)

Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities

Antiviral research, 2015-09, Vol.121, p.47-58

2015

Volltextzugriff (PDF)

Inhibition of Hec1 as a novel approach for treatment of primary liver cancer

Cancer chemotherapy and pharmacology, 2014-09, Vol.74 (3), p.511-520

2014

Volltextzugriff (PDF)

Hepatic Expression of Cell Proliferation Markers and Growth Factors in Giant Cell Hepatitis: Implications for the Pathogenetic Mechanisms Involved

Journal of pediatric gastroenterology and nutrition, 2011-01, Vol.52 (1), p.65-72

2011

Volltextzugriff (PDF)

Automated System for Multiplexing Detection of COVID-19 and Other Respiratory Pathogens

IEEE journal of translational engineering in health and medicine, 2023-01, Vol.11, p.424-434

2023

Volltextzugriff (PDF)

Safety, Tolerability, and Pharmacokinetics of ARC‐520 Injection, an RNA Interference‐Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers

Clinical pharmacology in drug development, 2017-07, Vol.6 (4), p.350-362

2017

Volltextzugriff (PDF)

Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent

Antiviral research, 2015-09, Vol.121, p.97-108

2015

Volltextzugriff (PDF)

A Systematic Review and Meta-Analysis of Clinical Effectiveness and Safety of Hydrogel Dressings in the Management of Skin Wounds

Frontiers in bioengineering and biotechnology, 2019-11, Vol.7, p.342-342

2019

Volltextzugriff (PDF)

Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial

Chest, 2017-05, Vol.151 (5), p.1069-1080

2017

Volltextzugriff (PDF)

Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China

Hong Kong medical journal = Xianggang yi xue za zhi, 2018-10, Vol.24 (5), p.492-500

2018

Volltextzugriff (PDF)

Activation and Deactivation of a Broad-Spectrum Antiviral Drug by a Single Enzyme: Adenosine Deaminase Catalyzes Two Consecutive Deamination Reactions

Antimicrobial Agents and Chemotherapy, 2003-01, Vol.47 (1), p.426-431

2003

Volltextzugriff (PDF)

MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2

Nature microbiology, 2016-02, Vol.1 (3), p.16004, Article 16004

2016

Volltextzugriff (PDF)

Apolipoprotein E Gene Revisited: Contribution of Rare Variants to Alzheimer’s Disease Susceptibility in Southern Chinese

Current Alzheimer research, 2021-01, Vol.18 (1), p.67-79

2021

Volltextzugriff (PDF)

Constrained evolution with respect to gene overlap of hepatitis B virus

Journal of molecular evolution, 1997, Vol.44 Suppl 1 (S1), p.S83-S90

1997

Volltextzugriff (PDF)

KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma

Journal of neuro-oncology, 2018-12, Vol.140 (3), p.519-527

2018

Volltextzugriff (PDF)

Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy

European journal of medicinal chemistry, 2020-04, Vol.191, p.112118-112118, Article 112118

2020

Volltextzugriff (PDF)

Mechanisms of Action of Ribavirin in Antiviral Therapies

Antiviral Chemistry and Chemotherapy, 2001-10, Vol.12 (5), p.261-272

2001

Volltextzugriff (PDF)

1 – 25 von 389

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(370)
Mit Volltextzugriff
(326)

Publikationsform

Sprache

Englisch
(388)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of Encequidar, First-in-Class Intestine Specific P‑glycoprotein Inhibitor

Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361)

Discovery and Characterization of Potent Dual P‑Glycoprotein and CYP3A4 Inhibitors: Design, Synthesis, Cryo-EM Analysis, and Biological Evaluations

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

Discovery of 4‑Aryl‑N‑arylcarbonyl-2-aminothiazoles as Hec1/Nek2 Inhibitors. Part I: Optimization of in Vitro Potencies and Pharmacokinetic Properties

Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1

RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg

Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities

Inhibition of Hec1 as a novel approach for treatment of primary liver cancer

Hepatic Expression of Cell Proliferation Markers and Growth Factors in Giant Cell Hepatitis: Implications for the Pathogenetic Mechanisms Involved

Automated System for Multiplexing Detection of COVID-19 and Other Respiratory Pathogens

Safety, Tolerability, and Pharmacokinetics of ARC‐520 Injection, an RNA Interference‐Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers

Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent

A Systematic Review and Meta-Analysis of Clinical Effectiveness and Safety of Hydrogel Dressings in the Management of Skin Wounds

Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial

Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China

Activation and Deactivation of a Broad-Spectrum Antiviral Drug by a Single Enzyme: Adenosine Deaminase Catalyzes Two Consecutive Deamination Reactions

MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2

Apolipoprotein E Gene Revisited: Contribution of Rare Variants to Alzheimer’s Disease Susceptibility in Southern Chinese

Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial

Constrained evolution with respect to gene overlap of hepatitis B virus

KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma

Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy

Mechanisms of Action of Ribavirin in Antiviral Therapies

Suchergebnisse filtern